Brief: Biofrontera Says Capital Measure Oversubscribed
18/08/2020 10:04
Aug 18 (Reuters) - BIOFRONTERA AG B8FGn.DE :
* CAPITAL MEASURE OVERSUBSCRIBED: PLACEMENT OF 1.00%
QUALIFIED
SUBORDINATED MANDATORY CONVERTIBLE BOND 2020/2021
* GROSS PROCEEDS FROM CAPITAL MEASURE AMOUNT TO EUR 7.9
MILLION.
Source text for Eikon: ID:nPex7y1pKa
Further company coverage: B8FGn.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Biofrontera AG
See all newsBrief: Biofrontera Says Co And Units Have Entered Into An Agreement With Biofrontera Inc About How To Settle Payment Obligations By Biofrontera Inc
Brief: Biofrontera AG Says Legal Dispute On Import In USA Will Result In Revised Outlook
Brief: Biofrontera AG Resolves Capital Increase From Authorized Capital
Brief: Biofrontera AG Says Plans Capital Reduction And Considers Subsequent Capital Increase From Authorized Capital
Brief: Biofrontera AG Says FY 2022 Total Revenue Amounted To EUR 25.7 Million